Mission Pharmacal announced the introduction of Urocit-K (potassium citrate) extended-release tablet in a 15mEq dosage strength. Urocit-K is an alkalinizing agent indicated for the treatment of renal tubular acidosis with calcium stones, hypocitraturic calcium oxalate nephrolithiasis, and uric acid lithiasis. Urocit-K is already available in 5mEq and 10mEq dosage strengths.

For more information call (210) 696-8400 or visit www.urocit-k.com.